{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:37:03Z","timestamp":1780450623566,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science and Technology Major Projects","award":["2018ZX10731301-002"],"award-info":[{"award-number":["2018ZX10731301-002"]}]},{"name":"National Science and Technology Major Projects","award":["2018ZX10731301-002"],"award-info":[{"award-number":["2018ZX10731301-002"]}]},{"name":"National Science and Technology Major Projects","award":["2018ZX10731301-002"],"award-info":[{"award-number":["2018ZX10731301-002"]}]},{"name":"Youth Science Fund Project of iCDC","award":["08065"],"award-info":[{"award-number":["08065"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-024-03724-4","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T05:13:46Z","timestamp":1736399626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the cross-immunity between Mycobacterium tuberculosis and Mycobacterium abscessus in vitro"],"prefix":"10.1186","volume":"25","author":[{"given":"Da","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanglin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haican","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongliang","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"3724_CR1","unstructured":"Organization WH. Global tuberculosis report 2023. World Health Organization; 2023."},{"issue":"4","key":"3724_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.tim.2010.12.008","volume":"19","author":"FJ Veyrier","year":"2011","unstructured":"Veyrier FJ, Dufort A, Behr MA. The rise and fall of the Mycobacterium tuberculosis genome. Trends Microbiol. 2011;19(4):156\u201361.","journal-title":"Trends Microbiol"},{"key":"3724_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1146\/annurev-micro-121321-093031","volume":"76","author":"CS Pepperell","year":"2022","unstructured":"Pepperell CS. Evolution of tuberculosis pathogenesis. Annu Rev Microbiol. 2022;76:661\u201380.","journal-title":"Annu Rev Microbiol"},{"issue":"4","key":"3724_CR4","first-page":"602","volume":"10","author":"GF Black","year":"2003","unstructured":"Black GF, et al. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults. Clin Diagn Lab Immunol. 2003;10(4):602\u201311.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"3724_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1046\/j.1365-2249.2003.02272","volume":"134","author":"RE Weir","year":"2003","unstructured":"Weir RE, et al. Interferon-gamma and skin test responses of schoolchildren in Southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria. Clin Exp Immunol. 2003;134(2):285\u201394.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"3724_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1086\/322042","volume":"184","author":"GF Black","year":"2001","unstructured":"Black GF, et al. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis. 2001;184(3):322\u20139.","journal-title":"J Infect Dis"},{"key":"3724_CR7","doi-asserted-by":"publisher","first-page":"809014","DOI":"10.1155\/2015\/809014","volume":"2015","author":"S Faria","year":"2015","unstructured":"Faria S, Joao I, Jordao L. General overview on nontuberculous mycobacteria, biofilms, and human infection. J Pathog. 2015;2015:809014.","journal-title":"J Pathog"},{"issue":"1","key":"3724_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s12879-019-4050-z","volume":"19","author":"S Tanaka","year":"2019","unstructured":"Tanaka S, et al. Pathogenicity of Mycolicibacterium Phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report. BMC Infect Dis. 2019;19(1):454.","journal-title":"BMC Infect Dis"},{"issue":"42","key":"3724_CR9","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.15585\/mmwr.mm7042a3","volume":"70","author":"EF Blau","year":"2021","unstructured":"Blau EF, et al. Mycobacterium porcinum skin and soft tissue infections after vaccinations - indiana, kentucky, and Septembertember 2018-february 2019. MMWR Morb Mortal Wkly Rep. 2021;70(42):1472\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"3724_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jinf.2021.05.019","volume":"83","author":"Y Tan","year":"2021","unstructured":"Tan Y, et al. Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: a prospective surveillance study. J Infect. 2021;83(1):46\u201353.","journal-title":"J Infect"},{"issue":"9","key":"3724_CR11","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1080\/21645515.2017.1335374","volume":"13","author":"CY Huang","year":"2017","unstructured":"Huang CY, Hsieh WY. Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: a systematic review and meta-analysis. Hum Vaccin Immunother. 2017;13(9):1960\u201371.","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"3724_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2217\/imt.12.25","volume":"4","author":"J Zhang","year":"2012","unstructured":"Zhang J, et al. Therapeutic effects of inhaled inactivated Mycobacterium phlei in adult patients with moderate persistent asthma. Immunotherapy. 2012;4(4):383\u20137.","journal-title":"Immunotherapy"},{"issue":"6","key":"3724_CR13","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.3892\/mmr.2016.5865","volume":"14","author":"M Ming","year":"2016","unstructured":"Ming M, et al. Inhalation of inactivated\u2013Mycobacterium phlei prevents asthma\u2013mediated airway hyperresponsiveness and airway eosinophilia in mice by reducing IL\u20135 and IL\u201313 levels. Mol Med Rep. 2016;14(6):5343\u20139.","journal-title":"Mol Med Rep"},{"issue":"6685","key":"3724_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/31159","volume":"393","author":"ST Cole","year":"1998","unstructured":"Cole ST, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393(6685):537\u201344.","journal-title":"Nature"},{"issue":"10","key":"3724_CR15","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/pmic.200600853","volume":"7","author":"H M\u00e5len","year":"2007","unstructured":"M\u00e5len H, et al. Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics. 2007;7(10):1702\u201318.","journal-title":"Proteomics"},{"issue":"1","key":"3724_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4161\/viru.22329","volume":"4","author":"MA Forrellad","year":"2013","unstructured":"Forrellad MA, et al. Virulence factors of the Mycobacterium tuberculosis complex. Virulence. 2013;4(1):3\u201366.","journal-title":"Virulence"},{"key":"3724_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mimet.2016.09.010","volume":"131","author":"AL Yang","year":"2016","unstructured":"Yang AL, et al. A simplified mycobacterial growth inhibition assay (MGIA) using direct infection of mouse splenocytes and the MGIT system. J Microbiol Methods. 2016;131:7\u20139.","journal-title":"J Microbiol Methods"},{"issue":"6","key":"3724_CR18","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1002\/vms3.1262","volume":"9","author":"F Li","year":"2023","unstructured":"Li F, et al. Research progress into the application of Mycobacterium phlei in veterinary medicine. Vet Med Sci. 2023;9(6):2617\u201324.","journal-title":"Vet Med Sci"},{"issue":"2","key":"3724_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0041-3879(74)90008-7","volume":"55","author":"JL Stanford","year":"1974","unstructured":"Stanford JL, Grange JM. The meaning and structure of species as applied to mycobacteria. Tubercle. 1974;55(2):143\u201352.","journal-title":"Tubercle"},{"issue":"11","key":"3724_CR20","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.2174\/138161209787846838","volume":"15","author":"J Stanford","year":"2009","unstructured":"Stanford J, et al. The common mycobacterial antigens and their importance in the treatment of disease. Curr Pharm Des. 2009;15(11):1248\u201360.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"3724_CR21","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.biomaterials.2008.10.034","volume":"30","author":"MJ Heffernan","year":"2009","unstructured":"Heffernan MJ, et al. The stimulation of CD8\u2009+\u2009T cells by dendritic cells pulsed with polyketal microparticles containing ion-paired protein antigen and poly(inosinic acid)-poly(cytidylic acid). Biomaterials. 2009;30(5):910\u20138.","journal-title":"Biomaterials"},{"issue":"11","key":"3724_CR22","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.vaccine.2016.01.049","volume":"34","author":"X Liu","year":"2016","unstructured":"Liu X, et al. A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice. Vaccine. 2016;34(11):1370\u20138.","journal-title":"Vaccine"},{"issue":"6","key":"3724_CR23","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.celrep.2014.11.023","volume":"9","author":"J Deng","year":"2014","unstructured":"Deng J, et al. Mycobacterium tuberculosis proteome microarray for global studies of protein function and immunogenicity. Cell Rep. 2014;9(6):2317\u201329.","journal-title":"Cell Rep"},{"issue":"7","key":"3724_CR24","doi-asserted-by":"publisher","first-page":"e1004516","DOI":"10.1371\/journal.pgen.1004516","volume":"10","author":"A Fay","year":"2014","unstructured":"Fay A, Glickman MS. An essential nonredundant role for mycobacterial DnaK in native protein folding. PLoS Genet. 2014;10(7):e1004516.","journal-title":"PLoS Genet"},{"key":"3724_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fcimb.2018.00031","volume":"8","author":"YM Chuang","year":"2018","unstructured":"Chuang YM, et al. Intranasal immunization with dnak protein induces protective mucosal immunity against tuberculosis in cd4-depleted mice. Front Cell Infect Microbiol. 2018;8:31.","journal-title":"Front Cell Infect Microbiol"},{"key":"3724_CR26","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.2217\/fmb-2018-0168","volume":"13","author":"PK Mehta","year":"2018","unstructured":"Mehta PK, Dharra R, Kulharia M. Could mycobacterial MelF protein (Rv1936) be used as a potential drug target? Future Microbiol. 2018;13:1211\u20134.","journal-title":"Future Microbiol"},{"issue":"1","key":"3724_CR27","doi-asserted-by":"publisher","first-page":"10084","DOI":"10.1038\/s41598-019-46295-5","volume":"9","author":"R Dharra","year":"2019","unstructured":"Dharra R, et al. Evaluation of in silico designed inhibitors targeting MelF (Rv1936) against Mycobacterium marinum within macrophages. Sci Rep. 2019;9(1):10084.","journal-title":"Sci Rep"},{"key":"3724_CR28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3389\/fmicb.2016.00795","volume":"7","author":"N Gcebe","year":"2016","unstructured":"Gcebe N, et al. Comparative genomics and proteomic analysis of four non-tuberculous mycobacterium species and Mycobacterium tuberculosis complex: occurrence of shared immunogenic proteins. Front Microbiol. 2016;7:795.","journal-title":"Front Microbiol"},{"issue":"1","key":"3724_CR29","doi-asserted-by":"publisher","first-page":"17791","DOI":"10.1038\/s41598-019-54108-y","volume":"9","author":"A Chandran","year":"2019","unstructured":"Chandran A, et al. Development of a diagnostic compatible BCG vaccine against bovine tuberculosis. Sci Rep. 2019;9(1):17791.","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"3724_CR30","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1471-2172-14-S1-S11","volume":"14","author":"M de los Angeles Garc\u00eda","year":"2013","unstructured":"de los Angeles Garc\u00eda M, et al. Evaluation of specific humoral immune response and cross reactivity against Mycobacterium tuberculosis antigens induced in mice immunized with liposomes composed of total lipids extracted from Mycobacterium smegmatis. BMC Immunol. 2013;14(Suppl 1):S11.","journal-title":"BMC Immunol"},{"issue":"41","key":"3724_CR31","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1016\/j.vaccine.2020.08.045","volume":"38","author":"Y Tomita","year":"2020","unstructured":"Tomita Y, et al. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: in silico analyses and a hypothesis. Vaccine. 2020;38(41):6352\u20136.","journal-title":"Vaccine"},{"key":"3724_CR32","unstructured":"Organization WH. Global tuberculosis report 2019. World Health Organization; 2019."},{"key":"3724_CR33","doi-asserted-by":"crossref","unstructured":"Domingo-Gonzalez R et al. Cytokines and chemokines in Mycobacterium tuberculosis infection. Microbiol Spectr. 2016;4(5).","DOI":"10.1128\/microbiolspec.TBTB2-0018-2016"},{"issue":"25","key":"3724_CR34","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1016\/j.cell.2023.11.002","volume":"186","author":"DI Kotov","year":"2023","unstructured":"Kotov DI, et al. Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis. Cell. 2023;186(25):5536\u2013e555322.","journal-title":"Cell"},{"key":"3724_CR35","doi-asserted-by":"crossref","unstructured":"Ritter K et al. High-dose Mycobacterium tuberculosis H37Rv infection in IL-17A- and IL-17A\/F-deficient mice. Cells. 2022;11(18).","DOI":"10.3390\/cells11182875"},{"key":"3724_CR36","doi-asserted-by":"publisher","first-page":"104959","DOI":"10.1016\/j.micpath.2021.104959","volume":"158","author":"Q Liu","year":"2021","unstructured":"Liu Q, Li W, Chen Y. Association of IL-4 rs2243250 polymorphism with susceptibility to tuberculosis: a meta-analysis involving 6794 subjects. Microb Pathog. 2021;158:104959.","journal-title":"Microb Pathog"},{"issue":"6","key":"3724_CR37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.tube.2012.07.004","volume":"92","author":"LM Verhagen","year":"2012","unstructured":"Verhagen LM, et al. Helminths and skewed cytokine profiles increase tuberculin skin test positivity in Warao amerindians. Tuberculosis (Edinb). 2012;92(6):505\u201312.","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"3724_CR38","doi-asserted-by":"publisher","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","volume":"2","author":"M Pai","year":"2016","unstructured":"Pai M, et al. Tuberculosis Nat Reviews Disease Primers. 2016;2(1):16076.","journal-title":"Tuberculosis Nat Reviews Disease Primers"},{"issue":"11","key":"3724_CR39","doi-asserted-by":"publisher","first-page":"109696","DOI":"10.1016\/j.celrep.2021.109696","volume":"36","author":"YJ Lu","year":"2021","unstructured":"Lu YJ, et al. CD4 T cell help prevents CD8 T cell exhaustion and promotes control of Mycobacterium tuberculosis infection. Cell Rep. 2021;36(11):109696.","journal-title":"Cell Rep"},{"issue":"3","key":"3724_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1084\/jem.193.3.271","volume":"193","author":"T Mogues","year":"2001","unstructured":"Mogues T, et al. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med. 2001;193(3):271\u201380.","journal-title":"J Exp Med"},{"issue":"6","key":"3724_CR41","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41590-023-01510-4","volume":"24","author":"M K\u00fcnzli","year":"2023","unstructured":"K\u00fcnzli M, Masopust D. CD4(+) T cell memory. Nat Immunol. 2023;24(6):903\u201314.","journal-title":"Nat Immunol"},{"issue":"8","key":"3724_CR42","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1086\/424571","volume":"190","author":"D Naniche","year":"2004","unstructured":"Naniche D, et al. Decrease in measles virus-specific CD4 T cell memory in vaccinated subjects. J Infect Dis. 2004;190(8):1387\u201395.","journal-title":"J Infect Dis"},{"issue":"39","key":"3724_CR43","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1016\/j.vaccine.2016.07.058","volume":"34","author":"R Tanner","year":"2016","unstructured":"Tanner R, et al. In vitro mycobacterial growth inhibition asaays: A tool for the assessment of protective immunity and evaluatiTuberculosisulosis vaccine efficacy. Vaccine. 2016;34(39):4656\u201365.","journal-title":"Vaccine"},{"key":"3724_CR44","doi-asserted-by":"crossref","unstructured":"Brennan MJ et al. The cross-species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010\u20132014. Clin Vaccine Immunol. 2017;24(9).","DOI":"10.1128\/CVI.00142-17"},{"issue":"2","key":"3724_CR45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.vaccine.2009.10.047","volume":"28","author":"K Kolibab","year":"2009","unstructured":"Kolibab K, et al. A practical in vitro growth inhibition assay for the evaluation of TB vaccines. Vaccine. 2009;28(2):317\u201322.","journal-title":"Vaccine"},{"issue":"2","key":"3724_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1517\/14712598.2016.1134483","volume":"16","author":"A Morales","year":"2016","unstructured":"Morales A, Cohen Z. Mycobacterium phlei cell wall-nucleic acid complex in the treatment of nonmuscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin. Expert Opin Biol Ther. 2016;16(2):273\u201383.","journal-title":"Expert Opin Biol Ther"},{"issue":"26","key":"3724_CR47","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1016\/j.vaccine.2014.03.047","volume":"32","author":"MI Gr\u00f6schel","year":"2014","unstructured":"Gr\u00f6schel MI, et al. Therapeutic vaccines for tuberculosis\u2013a systematic review. Vaccine. 2014;32(26):3162\u20138.","journal-title":"Vaccine"},{"issue":"1","key":"3724_CR48","doi-asserted-by":"publisher","first-page":"2171233","DOI":"10.1080\/21645515.2023.2171233","volume":"19","author":"Z Wen","year":"2023","unstructured":"Wen Z, et al. A recombinant Mycobacterium smegmatis-based surface display system for developing the T cell-based COVID-19 vaccine. Hum Vaccin Immunother. 2023;19(1):2171233.","journal-title":"Hum Vaccin Immunother"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-024-03724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-024-03724-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-024-03724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:03:27Z","timestamp":1736402607000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-024-03724-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3724"],"URL":"https:\/\/doi.org\/10.1186\/s12866-024-03724-4","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were conducted in accordance with animal welfare guidelines and approved by the Animal Experimental Ethical Committee of the Chinese Center for Disease Control and Prevention (No. 2022-025). Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}